Teach me pediatrics topics ASD , VSD, PDA - comparison table with etiology, pathogenesis,& hemodynamics, signs and symptoms, investigations, management, complications, Differentials

| Feature | ASD | VSD | PDA |
|---|---|---|---|
| Incidence | 13 per 10,000 live births; ~10% of all CHD | Most common CHD - 20-30% of all CHD | ~1 per 2000 births; incidence dramatically increases with prematurity (up to 75% at 28-30 weeks gestation) |
| Sex predilection | Female > Male (2:1) | Equal | Female > Male (2:1) |
| Embryologic basis | Failure of closure of the interatrial septum during development; septum primum/secundum anomaly | Incomplete closure of the interventricular septum | Persistence of the 6th aortic arch derivative connecting pulmonary artery to descending aorta |
| Types / Classification | Secundum (90%) - deficient septum secundum near fossa ovalis; Primum (5%) - near AV valves, often + AV valve defects; Sinus venosus (5%) - near SVC entry, may have anomalous pulmonary venous drainage | Perimembranous / paramembranous (80%) - membranous septum below aortic valve; Muscular (most common by number, multiple possible - "Swiss-cheese"); Inlet/AV canal - below tricuspid valve; Outlet/Supracristal - conal septum below pulmonary valve | Isolated (90%); also seen with complex CHD where duct-dependent circulation may be critical |
| Associated conditions | Down syndrome (primum type); Holt-Oram syndrome; Ellis-van Creveld syndrome | Trisomy 21 (Down), Trisomy 18; Tetralogy of Fallot (component); DiGeorge syndrome; Turner syndrome | Rubella syndrome; prematurity; Trisomy 21; high-altitude birth |
| Genetic/risk factors | Maternal rubella, alcohol, TBX5 mutation (Holt-Oram) | GATA4 mutations; maternal diabetes, alcohol | Prematurity is the biggest risk factor; maternal rubella |
| Feature | ASD | VSD | PDA |
|---|---|---|---|
| Shunt direction (initial) | Left atrium → Right atrium (L-to-R) | Left ventricle → Right ventricle (L-to-R) | Aorta → Pulmonary artery (L-to-R) - continuous, both systole and diastole |
| Driving pressure | Left atrial pressure slightly > Right atrial pressure (low pressure difference ~5 mmHg) | LV pressure >> RV pressure during systole (~120 vs 25 mmHg - large gradient) | Aortic systolic AND diastolic pressure > Pulmonary artery pressure (continuous gradient) |
| Primary hemodynamic consequence | Right heart volume overload → RV/RA enlargement; increased pulmonary blood flow | Left heart volume overload → LA and LV dilation; ± pulmonary hypertension depending on size | Left heart volume overload (LA, LV); reduced systemic diastolic pressure due to diastolic runoff |
| Qp:Qs | Can be >3:1 with large defects | >1.5:1 in moderate-severe defects | Depends on duct size; continuous flow in both phases |
| Pulmonary vascular effects | Pulmonary hypertension is uncommon/late in secundum ASD; PVR generally normal | Large defects → pulmonary HTN early in life; irreversible changes possible within first year | Large ducts → pulmonary HTN; Eisenmenger in 5% |
| Eisenmenger development | Rare in secundum ASD; possible with large or primum defects | ~10% of patients with large/unrestrictive VSDs | ~5% of isolated PDAs |
| Special hemodynamic feature | Transient R-to-L shunting with increased intrathoracic pressure (Valsalva, coughing) - paradoxical embolism risk | Small VSDs: negligible; Large VSDs: equal LV-RV pressures; diastolic filling abnormalities in LA | Diastolic shunt lowers aortic diastolic pressure → bounding pulses; "diastolic steal" from coronary/systemic circulation |
| Spontaneous closure | Rare (small secundum may reduce in size) | ~50% of small muscular VSDs; 80% close by 1 month; only 25% still closing by 12 months | Functional closure in 10-15 hours post-term birth; common in premature infants with indomethacin treatment |
| Feature | ASD | VSD | PDA |
|---|---|---|---|
| Presentation timing | Often asymptomatic until adulthood (3rd-5th decade); >70% symptomatic by 5th decade | Large defects: symptoms from birth/infancy; small defects: asymptomatic for years | Narrow PDA: asymptomatic; large PDA: failure to thrive, recurrent respiratory infections; premature infants: respiratory distress |
| Key symptoms | Exercise intolerance, dyspnea on exertion, fatigue, palpitations, recurrent respiratory infections in children | Heart failure symptoms: tachypnea, poor feeding, failure to thrive, recurrent respiratory infections, excessive sweating during feeds | Tachypnea, poor feeding, failure to thrive; dyspnea/palpitations in older patients |
| Cyanosis | Absent initially; appears only with Eisenmenger (differential cyanosis NOT typical for ASD) | Absent initially; cyanosis with Eisenmenger reversal | Absent initially; with Eisenmenger: differential cyanosis - lower extremity cyanosis/clubbing more than upper extremity (PA blood flows to descending aorta below left subclavian) |
| Heart sounds | Wide, FIXED splitting of S2 (hallmark - does not vary with respiration); P2 may be loud | Loud P2 if pulmonary hypertension; variable S2 splitting | Normal S2 obscured by murmur; P2 loud with pulmonary HTN |
| Murmur | Soft ejection systolic murmur at 2nd left intercostal space (increased flow across pulmonary valve, NOT across the defect itself); mid-diastolic rumble at lower left sternal border (increased tricuspid flow) if large shunt | Loud, harsh pan-systolic (holosystolic) murmur at left lower sternal border (3rd-4th ICS); thrill often palpable; small "restrictive" VSDs may have louder murmur (maladie de Roger) | Continuous "machinery" murmur at left infraclavicular area / 1st-2nd left ICS (Gibson murmur) - begins after S1, peaks at S2, continues through diastole; louder in left infraclavicular region |
| Pulse character | Normal | Normal or prominent if large shunt | Bounding/waterhammer pulses with wide pulse pressure (diastolic runoff into pulmonary circulation) |
| Precordial findings | Right ventricular heave (parasternal); dilated pulmonary artery palpable at 2nd left ICS | Palpable thrill at left lower sternal border; right ventricular heave if large | Left ventricular heave; bounding peripheral pulses |
| Other signs | Signs of right heart failure in adults | Hepatomegaly, failure to thrive in large VSDs | Tachycardia; hyperactive precordium |
| Investigation | ASD | VSD | PDA |
|---|---|---|---|
| ECG | Incomplete RBBB (rSr' pattern in V1, V2) - hallmark; Right axis deviation (secundum); Left axis deviation (primum); PR prolongation; atrial fibrillation/flutter in adults | Right ventricular hypertrophy (large defects); left atrial enlargement; left ventricular hypertrophy | Left ventricular hypertrophy; left atrial enlargement in large PDA; normal in small PDA |
| Chest X-ray | Pulmonary plethora (increased vascular markings both lung fields); dilated main PA and branches; RA and RV enlargement; aortic knuckle normal/small | Cardiomegaly; pulmonary plethora; LA and LV enlargement; prominent pulmonary artery | Cardiomegaly; pulmonary plethora; prominent ascending aorta and pulmonary artery; LA/LV enlargement; calcification at duct in older patients |
| Echocardiography | Diagnostic - identifies defect size/location; Doppler quantifies shunt (Qp:Qs) and PA pressures; may miss sinus venosus ASD on TTE → use TEE; bubble study (agitated saline) for PFO | Diagnostic - visualizes defect, quantifies shunt; identifies associated lesions; Doppler for PA pressure estimation | May not directly visualize duct but Doppler signal identifies it; assesses LA/LV size, PA pressure |
| Cardiac catheterization | "Step-up" in O2 saturation at right atrial level; Qp:Qs calculation; pulmonary vascular resistance | "Step-up" in O2 saturation at right ventricular level; Qp:Qs; PA pressure measurement; needed pre-operatively for older patients | "Step-up" at PA level; Qp:Qs ratio; catheterization for pulmonary vascular resistance assessment before closure in borderline cases |
| Special tests | TEE for sinus venosus or ambiguous TTE; cardiac MRI for complex anatomy | Cardiac MRI for complex VSDs; TEE intraoperatively | Cardiac catheterization if Eisenmenger suspected; CT angiography |
| Aspect | ASD | VSD | PDA |
|---|---|---|---|
| Medical (conservative) | Observation for small defects; manage arrhythmias with beta-blockers or calcium channel blockers; infective endocarditis (IE) prophylaxis NOT routinely needed | Observation for small VSDs (high spontaneous closure rate); diuretics + ACE inhibitors for heart failure; anti-failure treatment to allow spontaneous closure | Premature infants: Indomethacin (COX inhibitor - reduces prostaglandin E2) or Ibuprofen IV - accelerates closure; Acetaminophen (alternative); surgical ligation if pharmacotherapy fails |
| Interventional / Catheter-based | Transcatheter closure (now >60% of ASD interventions) - Amplatzer Septal Occluder for secundum defects up to 3.5 cm with adequate rims; requires adequate septal rims | Amplatzer device closure - good results; risk of heart block with paramembranous device closure (proximity to conduction system) | Transcatheter coil or device occlusion - treatment of choice in most centers; Amplatzer duct occluder |
| Surgical | Surgical patch closure (direct suture, autologous pericardium, or prosthetic patch) on cardiopulmonary bypass - indicated for primum, sinus venosus, and defects not suitable for device closure | Patch repair on CPB with moderate hypothermia and cardioplegic arrest; right atrial approach for most; right ventriculotomy for apical muscular VSDs; pulmonary artery band as temporizing for "Swiss-cheese" VSDs | Surgical ligation/division via left posterolateral thoracotomy - gold standard in premature infants not responding to indomethacin; video-assisted thoracoscopic surgery (VATS) available |
| Indications for closure | Right-sided heart enlargement with or without symptoms; Qp:Qs >1.5:1; before school age recommended | Large defects: repair in infancy to prevent irreversible pulmonary vascular changes; moderate defects: close if Qp:Qs >1.5:1; small restrictive: observe | Any hemodynamically significant PDA; small PDA: close due to endarteritis risk (0.45%/year after 2nd decade) |
| Contraindication to closure | Eisenmenger syndrome (irreversible pulmonary HTN) | Eisenmenger syndrome | Eisenmenger with R-to-L shunt; severe irreversible pulmonary HTN |
| Complication | ASD | VSD | PDA |
|---|---|---|---|
| Pulmonary hypertension / Eisenmenger | Late, less common in secundum; possible with large/primum defects | ~10% of large unrepaired VSDs; develops early (first year of life with large defects) | ~5% of isolated PDAs |
| Arrhythmias | Atrial fibrillation, atrial flutter, SVT - common in adults; intraatrial reentrant tachycardia post-surgical repair | Less common; conduction defects post-surgery (LBBB, heart block) | Atrial arrhythmias with large shunts |
| Heart failure | Right heart failure (RV volume overload); leading long-term morbidity | Biventricular failure with large VSDs; leading cause of death if large defect untreated | Congestive heart failure - leading cause of death in untreated isolated PDA (~30% mortality untreated) |
| Infective endocarditis / endarteritis | Low risk for unclosed ASD (IE prophylaxis not routinely recommended) | Risk present, especially with small VSDs (turbulent jet); prophylaxis considered | Endarteritis - ~0.45%/year especially with small PDA; rarely fatal with early antibiotic treatment |
| Paradoxical embolism / Stroke | R-to-L shunting (even transient with Valsalva) enables venous thrombus crossing to systemic circulation → CVA | Less significant | Differential embolism to lower extremities with Eisenmenger |
| Aortic regurgitation | Uncommon | Supracristal/outlet VSDs → aortic cusp prolapse → aortic regurgitation | Uncommon |
| Recurrent respiratory infections | Common in children with large shunts | Common with large left-to-right shunts | Common |
| Post-repair complications | Arrhythmias (scar-related AFL), residual shunt, device embolization | Residual VSD, heart block (esp. paramembranous device closure), arrhythmias | Recurrent PDA, chylothorax (surgical), vocal cord palsy (left recurrent laryngeal nerve injury) |
| Differential | Why it mimics | How to distinguish |
|---|---|---|
| Patent Foramen Ovale (PFO) | Like ASD but no fixed shunt at rest | PFO: no fixed shunt on TTE; only R-to-L with Valsalva on TEE + bubble study; no RA/RV enlargement |
| Pulmonary stenosis | Ejection systolic murmur at 2nd left ICS like ASD | PS: S2 is normally split but NOT fixed; harsh murmur with ejection click; RV hypertrophy on ECG; echo confirms |
| Mitral stenosis | Mid-diastolic murmur (large ASD may have tricuspid flow rumble) | MS: murmur at apex, opening snap, no fixed S2 split; LA not RA enlargement |
| VSD vs ASD | Both are left-to-right shunts | VSD: harsh holosystolic murmur LLSB with thrill; LV enlargement; O2 step-up at RV level; no fixed S2 split |
| VSD vs AVSD | Both septal defects | AVSD: left axis deviation on ECG; associated AV valve abnormality; Down syndrome common |
| PDA vs Aortopulmonary window | Both continuous murmurs | AP window: murmur at upper sternal border; diagnosed on echo/angio; requires surgical repair (no catheter closure) |
| PDA vs Peripheral pulmonic stenosis | Continuous murmur | PPS: radiates to axillae and back; no bounding pulses; seen in neonates, Williams syndrome, Alagille syndrome |
| PDA vs Aortic stenosis + AR (to-and-fro) | Continuous-sounding murmur | AS+AR: murmur changes with posture; maximal at aortic area; echocardiography diagnostic |
| Eisenmenger syndrome (any) | Cyanosis + pulmonary HTN may obscure original defect | History; differential cyanosis in PDA (toes > fingers); cardiac catheterization for O2 step-up level |
| ASD | VSD | PDA | |
|---|---|---|---|
| Where | Atrial septum | Ventricular septum | Aorta to PA |
| Murmur | Soft ESM (2nd LICS) + Fixed split S2 | Harsh PSM (LLSB) + thrill | Continuous "machinery" (left infraclavicular) |
| O2 step-up at | Right atrium | Right ventricle | Pulmonary artery |
| Heart enlarged | RV + RA | LV + LA (± RV with PHT) | LV + LA |
| ECG | IRBBB + RAD | RVH / LVH | LVH |
| Spontaneous closure | Rare | Common (small muscular) | Yes (term infants); indomethacin (premature) |
| Special feature | Fixed S2 split | Restrictive small VSD = louder murmur | Bounding pulses + wide pulse pressure |
| Eisenmenger | Rare | 10% (large) | 5% |
Next is cyanotic congenital heart diseases -etiolgy, pathogenesis & hemodynamics, cigns and symptoms, investigations management and complications comparison table

| TOF | TGA | Tricuspid Atresia | Truncus Arteriosus | TAPVR | |
|---|---|---|---|---|---|
| Full name | Tetralogy of Fallot | Transposition of Great Arteries (D-TGA) | Tricuspid Atresia | Persistent Truncus Arteriosus | Total Anomalous Pulmonary Venous Return |
| Incidence / Frequency | Most common cyanotic CHD beyond infancy; ~5% of all CHD | 2-3 per 10,000 live births; most common cyanotic CHD in neonates | 2-3% of all CHD; most common form of functionally single-ventricle physiology | 1-2% of all CHD; rare | 1-2% of all cardiac malformations |
| Pulmonary blood flow | Decreased | Increased | Decreased (usually) | Increased (massively) | Increased (but obstructed = emergency) |
| ECG pattern | RVH | RVH | LVH (unique - left ventricle does all the work) | BVH (biventricular hypertrophy) | RVH |

| Feature | TOF | TGA (D-TGA) | Tricuspid Atresia | Truncus Arteriosus | TAPVR |
|---|---|---|---|---|---|
| Embryologic defect | Anterosuperior displacement of the infundibular septum → abnormal septation between pulmonary trunk and aortic root; single embryologic error causing all 4 features | Failure of the aortopulmonary septum to spiral during division; results in aorta arising from RV and PA from LV (ventriculoarterial discordance with concordant AV connections) | Unequal division of the AV canal → absent tricuspid valve; mitral valve becomes larger than normal; RV is underdeveloped (hypoplastic) | Arrest of separation of the embryonic truncus arteriosus into aorta and PA; single great vessel overrides ventricular septum (VSD always present); neural crest cell migration failure | Failure of the pulmonary vein evagination from the posterior LA surface to fuse with pulmonary venous plexus around lung buds; persistent connection to splanchnic plexus |
| Associated conditions | Right-sided aortic arch (25%); ASD; anomalous coronary origin; 22q11 deletion (DiGeorge); Down syndrome | Usually isolated; associated with VSD (TGA-VSD) or intact ventricular septum (TGA-IVS); aortic arch hypoplasia/coarctation with VSD variant | ASD (obligatory - PFO/ASD needed to survive); VSD (variable); PDA (pulmonary blood flow often duct-dependent) | DiGeorge syndrome / 22q11 deletion (neural crest association); truncal valve abnormalities (bi- or quadricuspid 30-40%); anomalous coronary arteries (50%) | ASD/PFO (obligatory - only route for oxygenated blood to reach LA); associated with asplenia/polysplenia syndromes |
| Risk factors | Maternal diabetes; alcohol; phenylketonuria; rubella; genetic (22q11) | Maternal diabetes (strongest association); male sex predominance | Sporadic; occasional association with TGA | 22q11 microdeletion; sporadic | Sporadic; associated with asplenia syndrome |
| Sex ratio | M = F | Male predominance (2:1) | M = F | M = F | M = F |
| Feature | TOF | TGA (D-TGA) | Tricuspid Atresia | Truncus Arteriosus | TAPVR |
|---|---|---|---|---|---|
| Core anatomical defect | 4 components: (1) large unrestrictive VSD; (2) RVOTO (subpulmonic stenosis most common, also valvular or pulmonary atresia); (3) overriding aorta receiving blood from both ventricles; (4) RVH | Aorta arises from RV (anterior, rightward); PA arises from LV (posterior, leftward) - parallel circulations instead of normal series connection | No connection between RA and RV (tricuspid valve atretic); hypoplastic RV; obligatory ASD for survival; pulmonary flow via PDA or small VSD | Single great artery (truncus) overrides the VSD and gives rise to both aorta and PA; coronary arteries also from truncus | All 4 pulmonary veins drain into systemic venous system (RA or its tributaries) instead of LA; oxygenated blood reaches LA only via ASD/PFO |
| Shunt direction | R-to-L across VSD (due to RVOTO raising RV pressure above LV); deoxygenated blood enters aorta | Parallel circuits - no true shunting; pulmonary and systemic circulations run in parallel, not series; mixing only at level of ASD, VSD, or PDA | R-to-L at atrial level (RA → LA through ASD) | Obligatory mixing at truncal level (VSD + truncal valve); then non-restrictive L-to-R shunt into pulmonary circulation | Obligatory mixing at RA level; both venous streams mix in RA → L-to-R at atrial level (ASD/PFO) for LA filling |
| Mechanism of cyanosis | RVOTO diverts deoxygenated RV blood through VSD into overriding aorta → systemic desaturation | Aorta receives only deoxygenated systemic venous return (from RV); PA receives only oxygenated pulmonary venous return (from LV) - circulations are disconnected unless mixing occurs | Deoxygenated blood from RA crosses ASD into LA, mixes with pulmonary venous return, enters systemic circulation | Mixing of systemic and pulmonary venous blood at truncal level; SpO2 ~85% (depends on Qp:Qs ratio) | All oxygenated pulmonary venous blood diverted to RA; mixed (partially oxygenated) blood crosses ASD to LA |
| Pulmonary blood flow | Decreased (RVOTO restricts flow) | Increased (entire LV output goes to PA) - leads to pulmonary overcirculation | Decreased (usually duct-dependent) | Massively increased - entire cardiac output passes through both lungs; rapid development of pulmonary vascular disease | Depends on obstruction: Unobstructed TAPVR = increased (pulmonary overcirculation + CHF); Obstructed TAPVR = decreased (pulmonary edema, severe cyanosis - surgical emergency) |
| Hemodynamic consequence | RV pressure = LV pressure (unrestrictive VSD equalizes pressures); degree of cyanosis proportional to RVOTO severity; LV normal size | LV faces low pulmonary vascular resistance → LV may become thin and incapable of supporting systemic circulation over time; RA-LA mixing determines survival saturation | LV volume-overloaded (receives both systemic and pulmonary return); RA enlarged; RV hypoplastic | Volume + pressure overload of both ventricles; rapid pulmonary HTN development (may develop by 6 months); truncal valve stenosis/regurgitation adds to load | Right heart dilated; pulmonary hypertension common; with obstruction: pulmonary venous HTN, pulmonary edema |
| Tet spells (TOF only) | Paroxysmal hypercyanotic spells: acute RVOTO worsening (infundibular spasm) → more R-to-L shunting → severe cyanosis → hypoxia → acidosis → worsens spasm (vicious cycle) | N/A | N/A | N/A | N/A |
| Special physiology | "Pink TOF" - if RVOTO is mild, initial L-to-R shunt with no cyanosis (resembles VSD); RVOTO worsens as child grows → increasing cyanosis over time | Survival depends entirely on mixing at ASD, VSD, or PDA; TGA-IVS = most critical (no mixing without intervention) | Pulmonary blood flow duct-dependent in most; some (with large VSD + no RVOTO) may have excess pulmonary flow + CHF | Pulmonary HTN earliest of all 5 Ts - irreversible changes possible by 6 months | Infracardiac type TAPVR with obstruction = TRUE surgical emergency (only cardiac surgery emergency with no palliation option) |
| Feature | TOF | TGA (D-TGA) | Tricuspid Atresia | Truncus Arteriosus | TAPVR |
|---|---|---|---|---|---|
| Age of presentation | Not always at birth; worsening cyanosis over weeks-months; "pink TOF" may be asymptomatic initially | First days of life (especially TGA-IVS) - profound neonatal cyanosis | Within days of birth (duct-dependent pulmonary flow); some not until PDA closes | Neonatal period - CHF + cyanosis from birth | Unobstructed: CHF in first weeks; Obstructed: Severe cyanosis + respiratory distress at birth |
| Cyanosis | Progressive; worse with crying, feeding, exertion; relieved by squatting | Profound from birth (especially TGA-IVS); paradoxically "blue" despite normal-sounding heart initially | From birth; profound | Moderate; SpO2 ~85% (mixing at truncal level prevents extreme cyanosis) | Variable; obstructed type = profound cyanosis from birth |
| Squatting (TOF only) | Classic - child squats to relieve cyanosis: increases systemic vascular resistance → reduces R-to-L shunting → more blood goes to lungs | Not applicable | Not applicable | Not applicable | Not applicable |
| Tet spells | Hypercyanotic (Tet) spells: sudden onset intense cyanosis, irritability, hyperpnea, limpness, LOC; worst in morning/after feeding; may → syncope, CVA, death | No | No | No | No |
| Heart failure symptoms | Uncommon early (decreased pulmonary flow); failure to thrive | Tachypnea, poor feeding, tachycardia with large VSD variant (TGA-VSD); otherwise cardiac failure not prominent early | Uncommon (decreased flow); failure to thrive | Prominent CHF: tachypnea, poor feeding, diaphoresis, failure to thrive; CHF + cyanosis is classic combination | Unobstructed: CHF symptoms; Obstructed: severe respiratory distress, pulmonary edema |
| Murmur | Ejection systolic murmur at left sternal border (RVOTO); VSD itself is usually silent (unrestrictive = equal pressures); paradox: louder murmur = less severe TOF (more obstruction = softer murmur as less flow crosses RVOT) | Absent or soft murmur in TGA-IVS; murmurs relate to associated defects (VSD, PS) | Soft; related to associated VSD or ASD | Systolic murmur + sometimes diastolic component from truncal regurgitation; single S2 (only one semilunar valve) | Non-specific murmur or absent; features of right heart enlargement |
| S2 | Single S2 (pulmonary component absent/soft due to hypoplastic PA) | Single loud S2 (aorta is anterior - A2 is loud and P2 is posterior/obscured) | Variable | Single S2 (single semilunar valve) | May be widely split |
| Clubbing | Present - chronic hypoxemia | Present with uncorrected TGA | Present | Less prominent (SpO2 not as low) | Present with chronic uncorrected disease |
| Polycythemia | Present - compensatory; raises risk of cerebral venous thrombosis | Present in chronic cases | Present | Less marked | Present in unobstructed (long-standing) |
| Special signs | Infants: hyperpnea during spells; older children: growth retardation, exercise intolerance | "Egg on a string" appearance on CXR; profound cyanosis out of proportion to respiratory distress | Hepatomegaly; signs of RA enlargement | Bounding pulses (wide pulse pressure from pulmonary overcirculation); signs of CHF | Obstructed type: severe respiratory distress mimicking RDS |
| Investigation | TOF | TGA (D-TGA) | Tricuspid Atresia | Truncus Arteriosus | TAPVR |
|---|---|---|---|---|---|
| ECG | RVH (right axis deviation, tall R in V1); right ventricular strain pattern | RVH (right axis deviation - paradoxically RV is "systemic" ventricle); may look normal at birth | LVH (hallmark - LV does all work); Left axis deviation (superior QRS axis); RA enlargement | BVH (biventricular hypertrophy); combined ventricular enlargement | RVH; right axis deviation; P pulmonale; RBBB pattern |
| Chest X-ray | "Boot-shaped" heart (coeur en sabot): RVH elevates cardiac apex; concavity at pulmonary artery segment; decreased pulmonary vascular markings (oligemic lung fields); right-sided aortic arch in 25% | "Egg on a string" / "egg on its side": narrow superior mediastinum (great vessels overlapping = no thymic shadow), oval-shaped cardiac silhouette; increased pulmonary vascular markings (plethoric lung fields) | Cardiomegaly (RA + LV enlarged); normal or decreased pulmonary markings depending on pulmonary flow; left-sided cardiac apex (due to LV dominance) | Cardiomegaly (biventricular); increased pulmonary vascular markings; right-sided aortic arch in 30%; absent main PA segment (replaced by truncal artery) | "Snowman"/"Figure-of-8" appearance (supracardiac type - left SVC + left innominate vein form top of snowman + cardiac shadow = bottom); increased markings in unobstructed; white-out/pulmonary edema in obstructed |
| Echocardiography | Diagnostic: VSD, overriding aorta (>50% override), RVOTO, RVH; PA size assessment; coronary artery anatomy | Diagnostic: demonstrates AV concordance + ventriculoarterial discordance; identifies associated VSD, PS, ASD; LV morphology assessment for arterial switch timing | Shows absent tricuspid valve, hypoplastic RV, ASD, VSD; LV dilation; great vessel relationship; PDA assessment | Single truncal valve (trileaflet, bicuspid, or quadricuspid); VSD; PA origin from truncus; truncal valve regurgitation/stenosis | Identifies site of anomalous pulmonary venous drainage; presence/absence of obstruction; ASD/PFO; right heart dilation |
| Cardiac catheterization | O2 saturation step-DOWN at RV level; PA pressure low; coronary anatomy if echo inconclusive; not routine for diagnosis | O2 saturation "step-up" pattern complex; useful to assess pulmonary vascular resistance; less needed if echo diagnostic | Angiography shows anatomy; PA pressure and resistance measurement | PA pressures and resistance measurement (critical for surgical planning); truncal valve assessment | PA pressure and resistance; differentiate types; obstructed vs unobstructed |
| Cardiac MRI/CT | Coronary artery anatomy, PA branch sizes pre-operatively | LV mass and function assessment (pre-arterial switch); post-operative baffle assessment | Pre-Fontan anatomical mapping; pulmonary artery sizes | Pulmonary artery anatomy; coronary origins (50% anomalous) | Pulmonary vein anatomy; drainage pathway assessment |
| Hyperoxia test | PaO2 fails to rise significantly above 150 mmHg on 100% O2 (distinguishes cardiac from pulmonary cyanosis) | PaO2 fails to rise | PaO2 fails to rise | PaO2 minimal rise | PaO2 minimal rise |
| Aspect | TOF | TGA (D-TGA) | Tricuspid Atresia | Truncus Arteriosus | TAPVR |
|---|---|---|---|---|---|
| Emergency stabilization | PGE1 if duct-dependent (severe RVOTO/pulmonary atresia variant); Tet spell management: knee-chest position, IV morphine, IV beta-blocker (propranolol), IV phenylephrine (↑SVR), O2, fluids, correct acidosis | PGE1 immediately to maintain/open PDA for mixing; balloon atrial septostomy (Rashkind procedure) to create/enlarge ASD for adequate atrial mixing; achieves SpO2 70-80% | PGE1 if duct-dependent; stabilize with ASD if too small | PGE1 usually NOT used (would worsen pulmonary overcirculation); anti-failure therapy (diuretics, digoxin) | Obstructed TAPVR = true surgical emergency - no palliation possible; immediate surgery; PGE1 contraindicated (would worsen pulmonary overcirculation) |
| Palliative surgery | Blalock-Taussig (BT) shunt (modified - subclavian artery to PA with Gore-Tex conduit) if complete repair not feasible (small infant, hypoplastic PA); increases pulmonary blood flow | Balloon atrial septostomy (Rashkind) is itself palliative to bridge to definitive repair | Staged palliation (mandatory for single ventricle physiology): Stage 1: Blalock-Taussig shunt (if too little PBF) OR PA banding (if too much PBF); Stage 2: Glenn shunt (SVC to PA, bidirectional cavopulmonary connection) at ~6 months; Stage 3: Fontan completion (IVC to PA) at 2-4 years | PA banding if early repair not feasible | N/A for obstructed type (emergency repair only) |
| Definitive surgery | Complete intracardiac repair on CPB: VSD patch closure + RVOTO relief (resection of infundibular muscle, pulmonary valvotomy/valvectomy ± transannular patch); ideally in first 6 months | Arterial Switch Operation (ASO) / Jatene procedure - definitive repair; aorta re-anastomosed to LV, PA re-anastomosed to RV; coronary buttons transferred; must be done within first 2-3 weeks of life before LV "deconditions" to low pulmonary pressure | Fontan procedure (total cavopulmonary connection): IVC connected to PA; RA excluded from systemic circulation; single ventricle (LV) pumps to systemic and pulmonary circuits in series | Complete repair on CPB in neonatal period: (1) Pulmonary arteries detached from truncus + connected to RV via conduit; (2) VSD closed to direct LV output to truncus (aorta); early repair essential (pulmonary HTN by 6 months) | Surgical re-anastomosis of pulmonary veins to LA; ASD closure; resection of obstructing membrane; emergent in obstructed type |
| Historical operations (TGA) | N/A | Mustard/Senning procedure (atrial switch - now historical): intraatrial baffles redirect venous blood; physiologically corrected but morphologic RV remains systemic ventricle → long-term RV failure | N/A | N/A | N/A |
| Medical management | Propranolol for Tet spell prophylaxis; iron supplementation (iron deficiency worsens polycythemia complications) | PGE1 infusion preoperatively; anti-failure therapy for TGA-VSD with CHF | Diuretics + ACE inhibitors for volume overload; anti-coagulation post-Fontan (warfarin/aspirin) | Diuretics, digoxin, ACE inhibitors preoperatively; rapid deterioration means early surgical planning | Furosemide for pulmonary edema in obstructed type (bridge to surgery only) |
| Timing of definitive repair | Complete repair: ideally 3-6 months (avoid polycythemia complications); symptomatic neonates with duct-dependent flow: emergency BT shunt or primary repair | ASO: within first 2-3 weeks of life (before LV regression); TGA-VSD: up to 6-8 weeks | Glenn: ~6 months; Fontan: 2-4 years | Neonatal period (within first few weeks); do NOT delay - PVR irreversible by 6 months | Obstructed: immediate surgical emergency (hours); unobstructed: within first few weeks |
| Complication | TOF | TGA (D-TGA) | Tricuspid Atresia | Truncus Arteriosus | TAPVR |
|---|---|---|---|---|---|
| If untreated | Death; cerebral abscess (paradoxical emboli), cerebral venous thrombosis (polycythemia), progressive hypoxia, infective endocarditis | Death within weeks (TGA-IVS); progressive cyanosis and hypoxia | Death from hypoxia; high early mortality | Rapidly progressive CHF + pulmonary HTN; death usually in infancy | Obstructed: death in hours/days; unobstructed: CHF → death within months-years |
| Post-repair | Pulmonary regurgitation (most common long-term issue after transannular patch repair) → progressive RV dilation → RV failure → arrhythmias; residual RVOTO; residual VSD; ventricular arrhythmias / sudden death (RBBB + left anterior fascicular block = bifascicular block is common post-repair marker); pulmonary valve replacement often needed in adulthood | Atrial switch (historical): RV failure (morphologic RV as systemic ventricle), atrial arrhythmias, baffle obstruction/leak, sudden death; ASO: coronary artery problems (kinking/stenosis), neoaortic root dilation, pulmonary stenosis at anastomosis | Fontan circulation complications: protein-losing enteropathy (PLE - 10%), plastic bronchitis, Fontan failure, arrhythmias (atrial flutter), thromboembolism, hepatic fibrosis/cirrhosis (long-term), lymphatic dysfunction | Truncal valve regurgitation (progressive - most important); conduit failure/obstruction (RV-to-PA conduit requires replacement as child grows); pulmonary HTN if late repair | Pulmonary vein stenosis (most feared post-repair complication - difficult to treat); recurrent obstruction; arrhythmias; residual ASD |
| Infective endocarditis | Risk present (repaired/unrepaired) - IE prophylaxis recommended | Risk post-operatively | Risk present | Risk present | Risk present |
| Polycythemia/hyperviscosity | Cerebral venous thrombosis; cerebral abscess (paradoxical embolism through VSD) | Present | Present | Mild | Present |
| Arrhythmias | Ventricular arrhythmias post-repair (scarring from ventriculotomy); RBBB common; sudden cardiac death (lifetime risk) | Atrial arrhythmias (especially post-atrial switch) | Atrial arrhythmias (especially post-Fontan) | Conduction abnormalities | Arrhythmias post-repair |
| Feature | TOF | TGA | Tricuspid Atresia | Truncus Arteriosus | TAPVR |
|---|---|---|---|---|---|
| Cyanosis onset | Weeks-months | Day 1-2 of life | Within days | Birth | Birth (obstructed) or weeks (unobstructed) |
| Pulmonary flow | Decreased | Increased | Decreased | Massively increased | Increased (or obstructed = emergency) |
| CXR finding | Boot-shaped heart | Egg on string | Cardiomegaly + LAH | Cardiomegaly + plethora + no main PA shadow | Snowman sign (supracardiac type) |
| ECG hallmark | RVH | RVH | LVH + LAD | BVH | RVH |
| Emergency Rx | PGE1 (severe); Knee-chest for Tet spell | PGE1 + Rashkind septostomy | PGE1 | Anti-failure (NOT PGE1) | Immediate surgery (obstructed) |
| Definitive Rx | Complete repair + RVOTO relief | Arterial Switch Op (within 2-3 weeks) | Staged Fontan (Glenn → Fontan) | Neonatal complete repair | Pulmonary vein re-anastomosis to LA |
| Key complication | PR → RV failure; VT/SCD | RV failure (Mustard/Senning era); coronary stenosis (ASO) | Fontan failure, PLE | Truncal valve regurgitation; conduit failure | Pulmonary vein stenosis (post-repair) |
| Murmur character | Ejection systolic (RVOTO); single S2 | Absent/soft; single loud S2 | Variable | Systolic ± diastolic; single S2 | Non-specific or absent |
| Unique sign | Squatting; Tet spells | Cyanosis out of proportion to respiratory distress | LVH on ECG (paradox) | CHF + cyanosis together | Snowman CXR; "white-out" if obstructed |
Now teach me MS, MR, AS, AR, - etiology, pathogenesis hemodynamics, signs and symptoms, investigations management and complications, differential in comparison table

| Feature | MS (Mitral Stenosis) | MR (Mitral Regurgitation) | AS (Aortic Stenosis) | AR (Aortic Regurgitation) |
|---|---|---|---|---|
| Most common cause | Rheumatic fever (by far - 60% give history of RF; 40% of all rheumatic HD is MS) | Myxomatous degeneration (mitral valve prolapse) in developed countries; Rheumatic in developing countries | Degenerative calcific disease (trileaflet) in elderly (>65 yrs); Bicuspid aortic valve in younger adults (presents 1-2 decades earlier) | Bicuspid aortic valve (congenital); Rheumatic fever; Aortic root dilatation (Marfan, HTN, annuloaortic ectasia) |
| Rheumatic mechanism | Commissural fusion, leaflet thickening, chordal shortening/fusion, "fish-mouth" valve | Leaflet destruction + scarring; acute MR reversible; chronic MR → mixed MS/MR usually | Commissural fusion (less common now); fibrosis | Slow destruction of free cusp edges; commissural fusion |
| Degenerative / Calcific | Severe mitral annular calcification (MAC) in elderly | MAC stretching leaflets; papillary muscle dysfunction | Calcification of normal trileaflet cusps (most common in West); ~15% of those ≥65 yrs have AS | Dystrophic calcification of bicuspid valve |
| Congenital | Rare; congenital mitral stenosis | Mitral valve prolapse (MVP); cleft mitral valve (AVSD) | Bicuspid AV (commonest congenital AS) | Bicuspid AV; isolated congenital AR |
| Acute causes | N/A | Acute MR: infective endocarditis (IE), papillary muscle rupture post-MI, chordal rupture (MVP), trauma | N/A | Acute AR: infective endocarditis, aortic dissection, trauma; Takayasu arteritis |
| Other / Rare | Cor triatriatum (mimics MS), LA myxoma (ball-valve), radiation-induced, mucopolysaccharidosis | Functional MR: LV dilation → annular dilation; ischemic MR (papillary muscle dysfunction); carcinoid syndrome; radiation | Sub-aortic membrane (HOCM), supra-aortic stenosis (congenital) | Marfan syndrome, Ehlers-Danlos, syphilitic aortitis, Ankylosing spondylitis, Reactive arthritis (Reiter's), Rheumatoid arthritis, Takayasu |
| Sex predilection | Female > Male (2:1) for isolated MS | Female > Male for MVP; equal for other causes | Male > Female for calcific AS | Male > Female |
| Feature | MS | MR | AS | AR |
|---|---|---|---|---|
| Core mechanism | Mechanical obstruction to LV inflow → pressure overload of LA | Systolic backflow from LV → LA → volume overload of LA and LV | Mechanical obstruction to LV outflow → pressure overload of LV | Diastolic backflow from aorta → LV → volume overload of LV |
| Valve area (normal) | Normal MV area = 4-6 cm² | N/A (competence, not area) | Normal AV area = 2-4 cm² | N/A |
| Severity grading | Mild: >1.5 cm², gradient <5 mmHg; Moderate: 1.0-1.5 cm², 5-10 mmHg; Severe: <1.0 cm², >10 mmHg | Mild/Moderate/Severe based on regurgitant fraction; Severe: RF >50%, regurgitant vol >60 mL | Mild: AVA >1.5 cm²; Moderate: 1.0-1.5 cm²; Severe: <1.0 cm² or <0.6 cm²/m² BSA, mean gradient ≥40 mmHg, Vmax ≥4 m/s | Mild/Moderate/Severe; Severe: PHT <200 ms, regurgitant fraction >50%, vena contracta >6 mm |
| Primary chamber affected | LA (pressure rises; LA dilates) | LA + LV (both volume overloaded) | LV (hypertrophies concentrically) | LV (dilates eccentrically - largest hearts in medicine) |
| LV function | LV underfilled (starved); LV size normal or small; LV function preserved until late | LV volume overloaded; LV dilates; EF appears falsely high early (due to low afterload ejecting into LA) | LV hypertrophies (concentric); normal or small LV cavity; EF preserved until late | LV massively dilates (eccentric hypertrophy); EF eventually falls |
| Pulmonary circulation | Elevated LA pressure → pulmonary venous HTN → pulmonary arterial HTN → RV pressure overload → RV failure → TR | LA pressure elevated → pulmonary HTN in severe/chronic MR | LV hypertrophy → diastolic dysfunction → raised LVEDP → back-pressure to pulmonary circulation in late/severe disease | Increased LV volume → elevated LVEDP in decompensated disease → pulmonary HTN |
| Cardiac output | Reduced (LV underfilling); falls more with exercise or tachycardia (less diastolic filling time) | Maintained early (compensated); falls with decompensation | Maintained until late; critical reduction with decompensation; fixed low cardiac output = angina + syncope + failure | Maintained until decompensation |
| Pulse character | Low volume; tapping apex | Brisk, sustained displaced apex | Slow-rising, small volume (pulsus parvus et tardus) - in severe AS | Collapsing / waterhammer pulse (Corrigan's pulse) - wide pulse pressure due to diastolic runoff back into LV |
| Acute vs chronic hemodynamics | Always chronic | Acute MR: sudden massive LA pressure rise (normal-sized, non-compliant LA cannot accommodate) → acute pulmonary edema; Chronic MR: LA compliance increases, less pressure rise, tolerates large regurgitant volume | Usually chronic; LV adapts with hypertrophy over years | Acute AR: LV cannot dilate rapidly → LVEDP rises acutely → acute pulmonary edema + cardiogenic shock (emergency); Chronic AR: LV slowly dilates over years, well-tolerated until decompensation |
| Key physiologic difference | Inflow obstruction; RV affected | Volume overload; LV eccentric hypertrophy | Outflow obstruction; LV concentric hypertrophy | Volume overload + reduced coronary perfusion (low diastolic pressure) |
| Feature | MS | MR | AS | AR |
|---|---|---|---|---|
| Onset / Course | Latent period after RF (10-20 yrs); slowly progressive; symptoms often triggered by AF or pregnancy | Chronic: slow and insidious; Acute: sudden, catastrophic (APO) | Very long asymptomatic phase; sudden onset of symptoms marks critical transition | Chronic: long asymptomatic phase; Acute: sudden cardiovascular collapse |
| Symptoms triad / Cardinal symptoms | Dyspnea (most common); hemoptysis (pulmonary venous HTN); palpitations (AF) | Dyspnea on exertion; fatigue; palpitations; orthopnea | SAD triad: Syncope (exertional), Angina (exertional), Dyspnea (exertional/orthopnea); symptoms mark a critical prognostic threshold | Dyspnea on exertion (most common chronic symptom); palpitations (awareness of hyperdynamic circulation); angina (coronary ischemia from low diastolic pressure); acute AR: pulmonary edema, shock |
| Prognosis after symptoms | Progressive CHF; AF complications | Depends on cause; chronic MR: decline with LV dysfunction | Angina: mean survival 5 yrs; Syncope: 3 yrs; Heart failure: 1-2 yrs (classic mnemonic: "A5-S3-F1") | Chronic AR: 10+ yrs if managed; Acute AR: rapidly fatal if not treated |
| Apex beat | Tapping apex (accentuated S1 palpable); undisplaced; no heave | Displaced, hyperdynamic, thrusting apex (LV enlargement) | Heaving (sustained), non-displaced apex initially; displaced only with LV dilation (decompensation) | Displaced, hyperdynamic, thrusting apex (massive LV dilation) - "water-hammer" apex; visible neck pulsations (Corrigan's sign) |
| Heart sounds | S1 loud (snapping/tapping) - if pliable leaflet; S1 soft if calcified immobile valve; S2 normal or P2 loud (pulmonary HTN) | S1 soft (leaflets don't coapt fully); S3 gallop (volume overload, rapid early filling); P2 loud with pulmonary HTN | S1 normal; S2 soft/absent A2 (calcified, immobile leaflet); S4 gallop (reduced compliance of hypertrophied LV); paradoxical S2 split in severe AS (delayed LV emptying) | S1 soft; S2 soft A2 (poor leaflet coaptation); S3 in decompensated AR; Austin Flint murmur (see below) |
| Opening snap (OS) | Present - high-pitched, early diastolic snap immediately after S2; heard at apex/left sternal border; pliable non-calcified valve; A2-OS interval inversely proportional to severity (shorter A2-OS = more severe MS = higher LA pressure) | Absent | Absent | Absent |
| Murmur | Low-pitched, rumbling mid-diastolic murmur at apex; best heard in left lateral decubitus position with bell of stethoscope; presystolic accentuation (in sinus rhythm - atrial contraction); murmur intensity does NOT correlate with severity | Pansystolic (holosystolic) murmur at apex radiating to axilla (rheumatic/organic MR); or posterior (MVP with posterior leaflet prolapse); in MVP: mid-systolic click + late systolic murmur; murmur severity correlates with LA vs LV pressure gradient | Harsh, crescendo-decrescendo ejection systolic murmur at right upper sternal border (aortic area) radiating to carotids and apex; late-peaking = more severe AS; may be harsh at base but musical ("cooing dove") at apex (Gallavardin phenomenon) | High-pitched, blowing, decrescendo diastolic murmur at left sternal border (3rd-4th ICS); best heard with patient leaning forward in expiration; early diastolic = acute/severe AR (rapid pressure equalization); Austin Flint murmur: low-pitched mid-diastolic rumble at apex (regurgitant jet vibrates anterior mitral leaflet - mimics MS but no OS, no loud S1) |
| Peripheral signs | Mitral facies (malar flush - peripheral cyanosis + pink cheeks); AF irregular pulse | Brisk carotid upstroke (hyperdynamic); signs of heart failure | Pulsus parvus et tardus (slow-rising, small volume carotid pulse, especially in young); anacrotic pulse; systolic thrill in aortic area; carotid shudder | Corrigan's pulse (collapsing/waterhammer); de Musset's sign (head bobbing); Traube's sign (pistol-shot femorals); Müller's sign (uvular pulsations); Duroziez's sign (to-and-fro bruit over femoral artery); Quincke's sign (capillary pulsation in nailbed); Hill's sign: popliteal SBP exceeds brachial SBP by >20 mmHg |
| JVP | Elevated with pulmonary HTN + RV failure; large 'a' wave (if in SR) | Elevated with pulmonary HTN | Usually normal until decompensation | Usually normal until decompensation; may be elevated in acute AR |
| Investigation | MS | MR | AS | AR |
|---|---|---|---|---|
| ECG | P mitrale (bifid P wave, >0.12 sec, best in lead II) = LA enlargement; AF (most common arrhythmia - LA dilation); RVH if pulmonary HTN | P mitrale (LA enlargement); LVH (volume overload); AF in severe/chronic MR | LVH (voltage criteria + strain pattern: deep ST depression + T inversion in lateral leads V4-V6, I, aVL) = "LV strain pattern"; LBBB sometimes; first-degree AV block | LVH (tall QRS + strain); left axis deviation; LBBB in chronic severe AR |
| Chest X-ray | LA enlargement (double shadow at right heart border; splaying of carina - "carina angle >70°"; left atrial appendage bulge on left heart border = "straightening" of left heart border); Pulmonary venous congestion (upper lobe blood diversion, Kerley B lines, pulmonary edema); Pulmonary arterial HTN (main PA prominent); RV enlargement; NO LV enlargement (LV underfilled); valve calcification on lateral view | LA enlargement; LV enlargement (displaced apex); pulmonary vascular congestion in decompensated MR; Acute MR: pulmonary edema with near-normal cardiac size | LV hypertrophy (rounded LV contour); Post-stenotic dilatation of ascending aorta (prominent first right cardiac arch); Aortic valve calcification on lateral CXR (best seen fluoroscopy); cardiac size normal until decompensation | LV enlargement (massive - "cor bovinum" = ox heart in severe chronic AR); aortic root/ascending aorta dilation; Normal or enlarged LA; signs of pulmonary edema only in decompensation |
| Echocardiography - key findings | 2D: leaflet thickening, "hockey stick" doming of anterior leaflet, "fish-mouth" orifice on short axis, commissural fusion, subvalvular fusion; MVA by planimetry (most accurate); Doppler: mean gradient, pressure half-time (MVA = 220/PHT); Wilkins score (leaflet mobility, thickening, calcification, subvalvular involvement - guides PBMV eligibility) | Color Doppler: regurgitant jet size and direction; vena contracta width; proximal isovelocity surface area (PISA/ERO); LV size and function (EDD, ESD, EF); grading severity: mild, moderate, severe; MVP: posterior displacement of leaflet >2mm below mitral annular plane in parasternal long axis | 2D: calcified, restricted, thickened leaflets (bicuspid or trileaflet); reduced leaflet excursion; Doppler: peak velocity (Vmax), mean pressure gradient, AVA by continuity equation (AVA = (LVOT area × LVOT VTI)/AV VTI); Severe AS: AVA <1.0 cm², mean gradient ≥40 mmHg, Vmax ≥4 m/s | Color Doppler: regurgitant jet (vena contracta ≥6 mm = severe); jet width/LVOT width ratio; PHT (pressure half-time <200 ms = severe AR); pandiastolic flow reversal in descending aorta; LV dimensions (key for surgery timing: EDD >70 mm or ESD >50 mm) |
| Cardiac catheterization | Mitral valve gradient (LA-LV pressure difference); Gorlin formula for MVA; pulmonary artery pressure; still gold standard for hemodynamics; indicated when echo inconclusive or pre-operatively for coronary assessment | Left ventriculogram (LV injection shows contrast opacification of LA - grades 1-4); pulmonary artery wedge pressure; cardiac output | AVA by Gorlin formula: AVA = CO/44.3 × HR × SEP × √mean AV gradient; peak-to-peak gradient (aortic pullback); pressure equalization time; coronary angiography pre-AVR (most pts >40 yrs) | Aortography (regurgitant contrast fills LV - grades 1-4); pressure measurements; coronary angiography pre-AVR |
| Severity grading summary | Mild >1.5 cm²; Mod 1.0-1.5 cm²; Severe <1.0 cm² | Mild RF <30%; Mod 30-49%; Severe RF ≥50%, ERO ≥0.4 cm² | Mild AVA >1.5 cm²; Mod 1.0-1.5 cm²; Severe <1.0 cm², gradient ≥40 mmHg | Mild PHT >500 ms; Mod 200-500 ms; Severe PHT <200 ms, vena contracta ≥6 mm |
| Aspect | MS | MR | AS | AR |
|---|---|---|---|---|
| Medical - AF management | Rate control (beta-blockers, digoxin, CCBs) to prolong diastolic filling time; Anticoagulation (warfarin - AF + MS = very high stroke risk; target INR 2-3); rhythm control if symptomatic; no role for anticoagulation in pure sinus rhythm MS (but consider with spontaneous echo contrast or LA thrombus) | Rate control in AF; anticoagulation in AF | No specific role | Same as MS |
| Medical - symptoms | Diuretics for pulmonary congestion; beta-blockers for symptom control (heart rate reduction prolongs filling time); avoid vasodilators (preload-dependent state) | Diuretics for pulmonary congestion; ACE inhibitors/ARBs reduce afterload (beneficial in chronic severe MR with LV dysfunction); Beta-blockers for LV dysfunction | Diuretics cautiously (preload-dependent); avoid vasodilators/nitrates (may cause syncope - preload dependent); no proven medical therapy delays surgical need in AS | Vasodilators (ACE inhibitors, ARBs, nifedipine, hydralazine): reduce afterload and regurgitant fraction; indicated in chronic AR with LV dysfunction/symptoms not ready for surgery; diuretics for volume overload |
| Interventional / Percutaneous | PBMV (Percutaneous Balloon Mitral Valvuloplasty / Inoue technique) - treatment of choice if Wilkins score ≤8, no LA thrombus, no significant MR: balloon catheter inflated across MV through transseptal puncture; 1-year outcomes excellent in good candidates | MitraClip (TEER - Transcatheter Edge-to-Edge Repair): clip approximates anterior and posterior leaflet (Alfieri technique); indicated for high surgical risk patients with primary or secondary MR; EVEREST trial + COAPT trial evidence | TAVR (Transcatheter Aortic Valve Replacement): 1st line for high/intermediate/prohibitive surgical risk; PARTNER trials showed mortality benefit; now expanding to low-risk (younger) patients; risks include paravalvular leak, need for pacemaker, stroke, vascular complications | No percutaneous option for isolated AR currently (TAVR for AR with specific devices under evaluation) |
| Surgery - type | Open mitral commissurotomy (pliable non-calcified valve, no MR, no LA thrombus - ideal); Mitral Valve Replacement (MVR) - mechanical (young, needs anticoagulation) or bioprosthetic (elderly, RF) | Mitral Valve Repair (preferred over replacement - better survival, preserves LV function, no anticoagulation for bioprosthesis); Repair not possible: MVR | Surgical AVR (SAVR): gold standard for appropriate surgical risk; tissue vs mechanical valve; concurrent CABG if CAD; TAVR now preferred in many centers for intermediate-low risk elderly | Aortic Valve Replacement (AVR) - surgical (SAVR); TAVR emerging; aortic root replacement if significant aortic dilation (>5.0-5.5 cm in Marfan) |
| Indications for intervention | Symptomatic severe MS (MVA ≤1.5 cm²); Asymptomatic severe MS with systolic PAP >50 mmHg or new AF or recurrent emboli; PBMV if anatomy favorable (Wilkins ≤8) | Symptomatic severe primary MR (class I); Asymptomatic severe MR with: EF ≤60% OR ESD ≥40 mm; surgery preferred when repair feasible | Symptomatic severe AS (class I): any of SAD symptoms; Asymptomatic severe AS with: EF <50%, mean gradient >60 mmHg, exercise test showing symptoms, very severe AS (Vmax >5 m/s) | Symptomatic severe AR (class I); Asymptomatic severe AR with: EF <55% (class I) OR EDD >70 mm or ESD >50 mm (class IIa); concurrent cardiac surgery |
| Special considerations | Pregnancy with MS: PBMV can be done in 2nd trimester with lead shielding (radiation); rate control critical; high-risk delivery | Acute MR: emergency surgery; vasodilators (nitroprusside), IABP as bridge | Low-flow low-gradient AS (EF <50% + AVA <1 cm² + gradient <40 mmHg): dobutamine stress echo to distinguish truly severe AS from pseudosevere AS | Acute AR: emergency AVR; vasodilators + inotropes as bridge; IABP contraindicated (worsens AR by augmenting diastolic pressure → more regurgitation) |
| Complication | MS | MR | AS | AR |
|---|---|---|---|---|
| Atrial fibrillation | Very common (LA dilation); once AF develops → embolic risk rises dramatically; may cause acute decompensation (loss of atrial kick) | Common in chronic severe MR | Less common; may precipitate decompensation | Less common in chronic; can develop with decompensation |
| Systemic embolism / Stroke | Most feared - LA thrombus (especially appendage) → stroke; risk highest when AF develops; anticoagulation mandatory in MS + AF | Thrombus risk in AF; paradoxical embolism | Emboli less common than MS | Emboli possible (endocarditis) |
| Pulmonary hypertension | Very common - chronic LA → pulmonary venous HTN → reactive pulmonary arterial HTN → RV failure → TR | In severe chronic MR; secondary PHT | Late complication of decompensated AS | Late complication |
| Infective endocarditis (IE) | Relatively low risk for pure MS (no turbulent regurgitant jet); risk if associated MR | Higher risk - regurgitant turbulent jet damages leaflets; IE can cause chordal rupture → acute severe MR | Risk present - prophylaxis historically recommended; current guidelines selective | Higher risk - turbulent regurgitant jet; IE can perforate cusps → acute severe AR |
| Heart failure | Biventricular failure in advanced MS (RV fails secondary to PHT); also "cardiac cachexia" | LV failure; acute pulmonary edema in decompensation or acute MR | LV failure (late) - onset of HF = median survival 1-2 years untreated | LV failure - massive dilated LV eventually fails; acute AR = cardiovascular collapse |
| Hemoptysis | Classic - from pulmonary venous hypertension; epistaxis-like hemoptysis to frank pulmonary hemorrhage | Less prominent | Uncommon | Uncommon |
| Sudden cardiac death | Uncommon (more from PHT/RV failure) | Uncommon | Risk present - especially with severe symptomatic AS and exertion; AVR reduces SCD risk | Risk in decompensated LV failure |
| Post-surgical complications | PBMV: cardiac tamponade (5%), embolism (3%), death (3%), acute MR (2-5%); MVR: thromboembolism, paravalvular leak, endocarditis, structural deterioration (bioprosthetic) | MVR/repair: LV dysfunction, residual MR, prosthetic valve complications | SAVR/TAVR: stroke, pacemaker requirement (TAVR >SAVR), paravalvular leak (TAVR), prosthesis-patient mismatch | AVR: LV reverse remodeling (good sign); LV may not recover if too dilated too long before surgery |
| Differentials | MS | MR | AS | AR |
|---|---|---|---|---|
| Mimics the murmur | Austin Flint murmur (severe AR → mid-diastolic rumble at apex mimics MS); LA myxoma (tumor plop + diastolic murmur); Tricuspid stenosis (diastolic rumble at left sternal border, increases with inspiration); Cor triatriatum (membrane obstructs LA); Ball-valve LA thrombus | Tricuspid regurgitation (pansystolic at LLSB, increases with inspiration); VSD (pansystolic, LLSB, thrill); Aortic stenosis (Gallavardin effect - AS heard at apex); HOCM (ejection murmur at LSB) | HOCM (ejection systolic murmur at LSB; increases with Valsalva, standing; decreases with squatting - opposite to AS); Pulmonary stenosis (ejection systolic at 2nd LICS, with ejection click); Supravalvular AS (Williams syndrome); Innocent flow murmur in children | Pulmonary regurgitation (Graham Steell murmur - early diastolic at left sternal border, increases with inspiration, due to PHT); Austin Flint murmur of severe AR (mimics MS at apex, but AR itself has early diastolic murmur at LSB) |
| Key differentiator from each other | MS vs MR: MS = opening snap + loud S1 + mid-diastolic rumble; MR = soft S1 + pansystolic murmur | MR vs AS (apex murmur): MR = pansystolic, radiates to axilla; AS (Gallavardin) = crescendo-decrescendo, no radiation to axilla | AS vs HOCM: AS murmur decreases with Valsalva/standing; HOCM murmur increases; HOCM has systolic anterior motion (SAM) on echo | AR vs Graham Steell: Graham Steell has signs of severe PHT (RV heave, loud P2, TR), no signs of AR peripheral pulses |
| Feature | MS | MR | AS | AR |
|---|---|---|---|---|
| Valve problem | Doesn't open fully (diastole) | Doesn't close fully (systole) | Doesn't open fully (systole) | Doesn't close fully (diastole) |
| Timing of lesion | Diastolic obstruction | Systolic regurgitation | Systolic obstruction | Diastolic regurgitation |
| Primary overload | LA pressure | LA + LV volume | LV pressure | LV volume |
| LV | Small, underfilled | Dilated (eccentric) | Hypertrophied (concentric) | Massively dilated |
| Murmur | Mid-diastolic rumble (apex) + OS | Pansystolic (apex → axilla) | Ejection systolic (aortic area → carotids) | Early diastolic decrescendo (LSB) |
| Special sound | Opening snap; loud S1 | S3; soft S1 | Soft A2; S4; ejection click (bicuspid) | Austin Flint murmur; soft A2 |
| Pulse | Low volume | Brisk, hyperdynamic | Pulsus parvus et tardus | Collapsing/Corrigan's |
| CXR clue | LA enlargement, no LV enlargement | LA + LV enlargement | Post-stenotic aortic dilation, AV calcification | Massive LV enlargement |
| ECG | P mitrale, AF, RVH | P mitrale, LVH | LVH + strain | LVH, LBBB |
| Most common cause | Rheumatic fever | MVP (West) / Rheumatic (developing) | Calcific/degenerative (elderly), bicuspid (young) | Bicuspid AV / Rheumatic / Aortic root disease |
| Key intervention | PBMV (if favorable anatomy) | Repair > Replacement | SAVR / TAVR | AVR (no PBMV option) |
| Surgery trigger | Symptomatic MVA ≤1.5 cm² | EF ≤60% or ESD ≥40 mm | Any SAD symptom | EF <55% or EDD >70 mm |
| Do NOT use | Vasodilators (preload dependent) | - | Nitrates/vasodilators (syncope risk) | IABP (worsens AR) |